U.S. signs $2 billion vaccine deal with Pfizer and BioNTech
Published
The United States on on Tuesday signed a $1.95 billion agreement with U.S. pharma giant Pfizer and Germany's BioNTech for 100 million doses of their experimental COVID-19 vaccine,…
Full Article